BSE · GODAVARI.BO
Godavari Drugs Limited
₹128.00+₹4.80 (+3.9%)
Godavari Drugs Limited’s quoted price sits in the upper half of its reported 52-week range, 11.33% below the high.
Loading market information…
BSE · RAJNISH.BO · INR
Stock price
Quote as of Oct 30, 2026, 07:53 AM UTC. Cached market data; not a live quote.
One-year closing-price history · INR. Historical prices are not a forecast.
Rajnish Wellness Limited’s quoted price sits in the lower half of its reported 52-week range, 61.11% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE COMPANY BEHIND THE TICKER
Rajnish Wellness Ltd. operates in the market of consumer goods and traditional herbal remedies. The company provides a diverse selection of items, including solutions for sexual health, personal hygiene, and general healthcare, all distributed under its primary brand, Playwin. Rajnishkumar Surendraprasad Singh established the firm on June 13, 2015, and its corporate headquarters are located in Mumbai, India.
Latest available per-share figures in INR. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 08:11 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
₹128.00+₹4.80 (+3.9%)
Godavari Drugs Limited’s quoted price sits in the upper half of its reported 52-week range, 11.33% below the high.
₹133.80+₹6.35 (+4.98%)
Aspira Pathlab & Diagnostics Limited’s quoted price sits in the upper half of its reported 52-week range, 10.79% below the high.
₹212.95+₹1.05 (+0.5%)
Choksi Asia Limited’s quoted price sits in the upper half of its reported 52-week range, 20.08% below the high.
₹63.03-₹2.96 (-4.49%)
Concord Drugs Limited’s quoted price sits in the lower half of its reported 52-week range, 31.87% below the high.
₹28.64-₹0.77 (-2.62%)
Biofil Chemicals and Pharmaceuticals Limited’s quoted price sits in the lower half of its reported 52-week range, 38.2% below the high.
₹131.05-₹9.55 (-6.79%)
Vasundhara Rasayans Limited’s quoted price sits in the lower half of its reported 52-week range, 40.43% below the high.
₹6.26-₹0.19 (-2.95%)
Vista Pharmaceuticals Limited’s quoted price sits in the lower half of its reported 52-week range, 39.16% below the high.
₹13.74-₹0.21 (-1.51%)
Vivo Bio Tech Limited’s quoted price sits in the lower half of its reported 52-week range, 61.58% below the high.
